Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy

Fig. 4

Overall survival curves comparison of high or low expression of PIAS family genes in pan-cancer by using Kaplan–Meier Plotter database. A PIAS3 in BLCA, n = 485; B PIAS4 in CESC, n = 394; C PIAS1 in ESCA, n = 182; D PIAS4 in HNSC, n = 182; E PIAS1, PIAS2 in KIRC, n = 777; F PIAS2, PIAS3, PIAS4 in KIRP, n = 373; G PIAS2 in LUAD, n = 601; H PIAS3 in LUSC, n = 632; I PIAS4 in PCPG, n = 234; J PIAS1, PIAS2, PIAS3, PIAS4 in LIHC, n = 704; K PIAS2 in OV, n = 503; L PIAS3 in SARC, n = 353; M PIAS2, PIAS3, PIAS4 in PAAD, n = 261; N PIAS1, PIAS3, PIAS4 in STAD, n = 564; O PIAS2, PIAS3 in THCA, n = 671; P PIAS3, PIAS4 in THYM, n = 485. Q PIAS2, PIAS4 in UCEC, n = 713

Back to article page